Yue Ma1,2, Chunquan Zheng3, Le Shi1,2. 1. Department of Otolaryngology-Head and Neck Surgery, Eye Ear Nose and Throat Hospital, Fudan University, 83 Fenyang Road, Xuhui District, Shanghai, 200031, People's Republic of China. 2. Shanghai Key Clinical Disciplines of Otorhinolaryngology, Shanghai, People's Republic of China. 3. Department of Otolaryngology-Head and Neck Surgery, Eye Ear Nose and Throat Hospital, Fudan University, 83 Fenyang Road, Xuhui District, Shanghai, 200031, People's Republic of China. zheng_ent96@163.com.
Abstract
BACKGROUND: Many Chinese patients who experience chronic rhinosinusitis with nasal polyps (CRSwNP) have been shown to exhibit specifically enhanced TH1/TH17 responses and excessive neutrophil accumulation without demonstrating significant eosinophilia. These patients may be subject to different pathologies and therapies compared to Western patients. YKL40 can be produced by neutrophil and is associated with many inflammatory diseases, while its role in the pathogenesis of chronic rhinosinusitis (CRS) has yet to be determined. OBJECTIVE: The aim of this study was to investigate the relationship between the expression level and biologic role of YKL40 in CRS. METHODS: YKL40 expression was examined via quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), immunohistochemistry, and Western blot. Human nasal epithelia cells (HNECs) were isolated to detect YKL40 expression in response to specific inflammatory stimulation. RESULTS: YKL40 expression levels were significantly higher in NP patients compared to the turbinates of CRSsNP/CRSwNP and the control group and can be strongly activated by stimulation with IL-4 in vitro and suppressed by the other pro-inflammatory cytokines; lipopolysaccharide (LPS) and dexamethasone also caused significant decreases in YKL40 expression in HNECs. CONCLUSIONS: YKL40 may play a significant role in Chinese patients with CRSwNP. The molecular mechanisms identified here may aid in the design of new therapeutic strategies for improving the clinical outcomes of Chinese patients.
BACKGROUND: Many Chinese patients who experience chronic rhinosinusitis with nasal polyps (CRSwNP) have been shown to exhibit specifically enhanced TH1/TH17 responses and excessive neutrophil accumulation without demonstrating significant eosinophilia. These patients may be subject to different pathologies and therapies compared to Western patients. YKL40 can be produced by neutrophil and is associated with many inflammatory diseases, while its role in the pathogenesis of chronic rhinosinusitis (CRS) has yet to be determined. OBJECTIVE: The aim of this study was to investigate the relationship between the expression level and biologic role of YKL40 in CRS. METHODS:YKL40 expression was examined via quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), immunohistochemistry, and Western blot. Humannasal epithelia cells (HNECs) were isolated to detect YKL40 expression in response to specific inflammatory stimulation. RESULTS:YKL40 expression levels were significantly higher in NP patients compared to the turbinates of CRSsNP/CRSwNP and the control group and can be strongly activated by stimulation with IL-4 in vitro and suppressed by the other pro-inflammatory cytokines; lipopolysaccharide (LPS) and dexamethasone also caused significant decreases in YKL40 expression in HNECs. CONCLUSIONS:YKL40 may play a significant role in Chinese patients with CRSwNP. The molecular mechanisms identified here may aid in the design of new therapeutic strategies for improving the clinical outcomes of Chinese patients.
Authors: Richard M Rosenfeld; Jay F Piccirillo; Sujana S Chandrasekhar; Itzhak Brook; Kaparaboyna Ashok Kumar; Maggie Kramper; Richard R Orlandi; James N Palmer; Zara M Patel; Anju Peters; Sandra A Walsh; Maureen D Corrigan Journal: Otolaryngol Head Neck Surg Date: 2015-04 Impact factor: 3.497
Authors: Yang Zhou; Hong Peng; Huanxing Sun; Xueyan Peng; Chuyan Tang; Ye Gan; Xiaosong Chen; Aditi Mathur; Buqu Hu; Martin D Slade; Ruth R Montgomery; Albert C Shaw; Robert J Homer; Eric S White; Chang-Min Lee; Meagan W Moore; Mridu Gulati; Chun Geun Lee; Jack A Elias; Erica L Herzog Journal: Sci Transl Med Date: 2014-06-11 Impact factor: 17.956
Authors: Peter Tomassen; Thibaut Van Zele; Nan Zhang; Claudina Perez-Novo; Nicholas Van Bruaene; Philippe Gevaert; Claus Bachert Journal: Proc Am Thorac Soc Date: 2011-03
Authors: Mark Hew; Pankaj Bhavsar; Alfons Torrego; Sally Meah; Nadia Khorasani; Peter J Barnes; Ian Adcock; Kian Fan Chung Journal: Am J Respir Crit Care Med Date: 2006-04-13 Impact factor: 21.405
Authors: Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Claus Bachert; James Baraniuk; Fuad M Baroody; Michael S Benninger; Itzhak Brook; Badrul A Chowdhury; Howard M Druce; Stephen Durham; Berrylin Ferguson; Jack M Gwaltney; Michael Kaliner; David W Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F Piccirillo; Patricia Rohane; Ronald Simon; Raymond G Slavin; Alkis Togias; Ellen R Wald; S James Zinreich Journal: J Allergy Clin Immunol Date: 2004-12 Impact factor: 10.793
Authors: Nicholas Van Bruaene; Lara Derycke; Claudina Angela Perez-Novo; Philippe Gevaert; Gabriele Holtappels; Natalie De Ruyck; Claude Cuvelier; Paul Van Cauwenberge; Claus Bachert Journal: J Allergy Clin Immunol Date: 2009-06-04 Impact factor: 10.793